Skip to main content

PSC

ETF
—
—

Performance overview

PSC Price
Price Chart

Forward-looking statistics

Beta
0.93
Risk
19.69%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with small market capitalizations at the time of purchase. For this fund, companies with small market capitalizations are those with market capitalizations within the range of companies comprising the Russell 2000 Index.

Fund info

Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with small market capitalizations at the time of purchase. For this fund, companies with small market capitalizations are those with market capitalizations within the range of companies comprising the Russell 2000 Index.

Investing methodActively Managed
DiversifiedYes
Expense ratio—
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.44
Revenue per share—
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$3M
Put-call ratioN/A

Macro factor sensitivity

Growth+0.5
Credit+4.5
Liquidity-0.3
Inflation-1.8
Commodities-0.4
Interest Rates-1.5

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayJuly 1, 2025

News

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum

Century Therapeutics (IPSC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks Investment Research (June 25, 2025)
Inside Small-Cap's 3-Year Best Surge in Popularity: ETFs in Focus

Wall Street's newfound bullishness on small caps reflects a notable shift in market dynamics, with several analysts predicting continued growth.

Zacks Investment Research (January 17, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free